ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 159 filers reported holding ANIKA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,777,000 | +23.7% | 77,137 | +20.9% | 0.00% | 0.0% |
| Q3 2016 | $3,053,000 | -11.0% | 63,801 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $3,429,000 | +27.1% | 63,907 | +5.9% | 0.00% | 0.0% |
| Q1 2016 | $2,698,000 | +19.1% | 60,339 | +1.6% | 0.00% | +33.3% |
| Q4 2015 | $2,266,000 | +20.6% | 59,388 | +0.6% | 0.00% | 0.0% |
| Q3 2015 | $1,879,000 | -4.5% | 59,036 | -0.9% | 0.00% | +50.0% |
| Q2 2015 | $1,968,000 | -5.5% | 59,590 | +17.8% | 0.00% | -33.3% |
| Q1 2015 | $2,083,000 | +2.5% | 50,596 | +1.5% | 0.00% | 0.0% |
| Q4 2014 | $2,032,000 | +10.6% | 49,869 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $1,838,000 | -17.7% | 50,135 | +4.0% | 0.00% | 0.0% |
| Q2 2014 | $2,232,000 | +27.3% | 48,186 | +13.0% | 0.00% | 0.0% |
| Q1 2014 | $1,753,000 | +8.3% | 42,647 | +0.6% | 0.00% | +50.0% |
| Q4 2013 | $1,618,000 | +82.8% | 42,410 | +14.4% | 0.00% | +100.0% |
| Q3 2013 | $885,000 | +44.1% | 37,056 | +2.6% | 0.00% | 0.0% |
| Q2 2013 | $614,000 | – | 36,126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 591,675 | $17,513,580 | 14.58% |
| Trigran Investments, Inc. | 1,564,541 | $46,310,413 | 4.64% |
| DIKER MANAGEMENT LLC | 22,458 | $664,757 | 0.77% |
| Virtus Fund Advisers, LLC | 3,490 | $103,304 | 0.74% |
| Portolan Capital Management | 207,900 | $6,153,840 | 0.61% |
| Virtus Investment Advisers, Inc. | 16,086 | $476,146 | 0.32% |
| Ranger Investment Management | 140,205 | $4,150,068 | 0.31% |
| BOOTHBAY FUND MANAGEMENT, LLC | 367,510 | $10,878,296 | 0.25% |
| Riverwater Partners LLC | 9,778 | $289,429 | 0.25% |
| Legato Capital Management LLC | 7,556 | $223,658 | 0.04% |